Alexium International Group (AJX) AI Stock Analysis

• Market Cap: AU$10.80M
• Dividend Yield: N/A
• Average Volume (3M): 135.26K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.72
• Revenue Growth: -32.85%
• EPS Growth: 28.30%
• Country: AU
• Employees: 319
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): >-0.01
• Shares Outstanding: 1,638,393,000
• 10 Day Avg. Volume: 118,241
• 30 Day Avg. Volume: 135,260
• PEG Ratio: -0.05
• Price to Book (P/B): -18.05
• Price to Sales (P/S): 1.85
• P/FCF Ratio: -2.60
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Sell
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 37 Underperform
• Price Target: <AU$0.01 ▼(-10.00% Downside)

The overall stock score is heavily impacted by the company's poor financial performance, characterized by declining revenues, persistent losses, and a weak balance sheet. The lack of technical analysis data and negative valuation metrics further contribute to the low score. The absence of earnings call insights and corporate events means these factors do not influence the score.

Positive Factors

Proprietary Technologies

Alexium's proprietary technologies in flame retardancy and water repellency provide a competitive edge, fostering long-term partnerships and recurring revenue streams.

Strategic Partnerships

These partnerships leverage Alexium's technologies, ensuring a steady revenue stream and enhancing market position in the textile industry.

R&D and Market Expansion

Continuous R&D efforts can lead to new product offerings and market expansion, driving future growth and sustaining competitive advantage.

Negative Factors

Declining Revenues

Declining revenues suggest weakening demand or competitive pressures, which could hinder long-term growth and profitability.

Weak Balance Sheet

A weak balance sheet with high leverage and negative equity indicates financial instability, limiting the company's ability to invest in growth opportunities.

Negative Cash Flows

Negative cash flows reflect operational inefficiencies and financial distress, posing challenges to sustaining operations and funding future growth.

Alexium International Group Business Overview & Revenue Model

Company Description

Alexium International Group Limited manufactures and sells phase-change material (PCM) and other specialty textile solutions in the United States. It offers thermal regulation solutions, such as Alexicool, a PCM chemical finish for fabrics; Biocool, a natural and biobased PCM cooling for textile and foam bedding applications; and Eclipsys, a perpetual cooling technology that enhance the cooling experience for textile and foam bedding systems. The company also provides flame retardant solutions, such as Alexiflam, a flame-retardant treatment for cotton, linen, and other cellulosic textiles, as well as mattress applications. It serves bedding, military, and workwear markets. The company was incorporated in 1994 and is based in Greer, South Carolina.

How the Company Makes Money

Alexium International Group generates revenue primarily through the sale of its specialty chemical products and advanced material technologies. The company has established key revenue streams by partnering with textile manufacturers and industrial coating companies, providing them with innovative solutions that enhance their product offerings. Significant partnerships with major brands and manufacturers in the textile industry allow Alexium to leverage its proprietary technologies, leading to recurring revenue from licensing agreements and product sales. Additionally, the company may experience revenue growth through ongoing research and development efforts aimed at creating new products and applications, thus expanding its market reach.

Alexium International Group Financial Statement Overview

Summary

Alexium International Group is facing significant financial challenges, with declining revenues, persistent losses, and a weak balance sheet characterized by high leverage and negative equity. Cash flow issues further exacerbate the company's financial health, indicating a need for strategic restructuring or capital infusion to stabilize operations.

Income Statement

The company has experienced declining revenue over the past few years, with a significant drop of 13.79% in the most recent year. Gross profit margins have been relatively stable but are overshadowed by negative net profit margins, indicating ongoing losses. The EBIT and EBITDA margins are also negative, reflecting operational inefficiencies and financial distress.

Balance Sheet

The balance sheet shows a concerning level of debt relative to equity, with a negative equity position in the latest year, leading to an undefined debt-to-equity ratio. The return on equity is positive due to negative equity, which is misleading. The equity ratio is negative, indicating financial instability and potential solvency issues.

Cash Flow

The company has negative operating and free cash flows, although there has been some improvement in free cash flow growth. The operating cash flow to net income ratio is negative, indicating cash flow issues. The free cash flow to net income ratio is slightly above 1, suggesting that free cash flow is somewhat aligned with net income, despite both being negative.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	4.55M	3.92M	5.89M	7.19M	8.14M	7.29M
Gross Profit	2.04M	1.69M	2.64M	2.81M	3.32M	2.65M
EBITDA	-1.70M	-3.25M	-962.00K	-1.38M	-1.54M	147.52K
Net Income	-2.14M	-3.93M	-2.76M	-2.95M	-3.36M	-1.45M
Balance Sheet
Total Assets	5.23M	2.88M	5.23M	5.37M	6.40M	10.49M
Cash, Cash Equivalents and Short-Term Investments	2.05M	662.45K	2.05M	511.78K	1.02M	2.94M
Total Debt	969.43K	2.55M	969.43K	4.69M	3.85M	3.46M
Total Liabilities	1.93M	3.28M	1.93M	6.35M	4.83M	6.31M
Stockholders Equity	3.30M	-402.08K	3.30M	-980.26K	1.57M	4.18M
Cash Flow
Free Cash Flow	-1.35M	-2.80M	-1.35M	-1.49M	-1.93M	-1.51M
Operating Cash Flow	-1.19M	-2.58M	-1.19M	-1.10M	-1.57M	-1.39M
Investing Cash Flow	-156.22K	-218.09K	-156.22K	-385.41K	-353.35K	-882.65K
Financing Cash Flow	2.91M	1.42M	2.91M	992.85K	74.01K	323.38K

Alexium International Group Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
CG1	55 Neutral	AU$42.24M	-5.25	-67.76%	―	7.08%	33.70%
SDV	53 Neutral	AU$82.69M	-94.57	-1.75%	―	-5.37%	-140.00%
CXL	52 Neutral	AU$112.10M	-5.39	-22.28%	―	16.47%	29.53%
SPN	48 Neutral	AU$19.50M	-6.93	-63.81%	―	―	52.66%
AJX	37 Underperform	AU$10.80M	-2.63	-263.52%	―	-32.85%	28.30%
DTZ	28 Underperform	AU$27.34M	-2.90	-869.14%	―	340.27%	19.44%

Alexium International Group Corporate Events

Alexium International Announces AGM Results and Shareholder Resolutions

Alexium International Group Limited announced the results of its Annual General Meeting, detailing the outcomes of various resolutions voted on by its shareholders. Key resolutions included the adoption of the remuneration report, re-election and election of directors, approval of the employee securities incentive plan, and the issuance of shares in lieu of director fees. All resolutions were carried, indicating strong shareholder support and potentially positive implications for the company’s governance and strategic direction.

Alexium International Group’s 2025 AGM Highlights Leadership and Strategy

Alexium International Group Limited held its 2025 Annual General Meeting, where key company figures such as Interim Chair Simon Moore and CEO William Blackburn were present. The meeting focused on the company’s strategic direction and leadership, with implications for its future operations and market positioning.

Alexium International Group Announces Livestream Details for Upcoming AGM

Alexium International Group Limited announced the livestream link for its upcoming Annual General Meeting (AGM) scheduled for 21 November 2025. The meeting will be held in Sydney, Australia, and virtual attendees can participate by asking questions through the Teams platform, although voting requires in-person attendance. This announcement facilitates stakeholder engagement by providing a virtual platform for participation, reflecting the company’s commitment to transparency and accessibility.

Alexium Announces Leadership Transition in Finance Department

Alexium International Group Limited announced the resignation of its Vice President of Finance, Lisa Hubka, effective January 7, 2026, with Heather White appointed as her successor. This leadership change is part of a strategic transition to ensure continuity in financial management, reflecting the company’s ongoing commitment to innovation and market leadership in performance chemicals.

Alexium International Group Announces 2025 AGM Details

Alexium International Group Limited has announced the arrangements for its 2025 Annual General Meeting, inviting shareholders to participate in person or via a live stream. The meeting will be held on November 21, 2025, and shareholders are encouraged to submit proxy forms online by November 19, 2025. This meeting is a critical opportunity for stakeholders to engage with the company’s strategic direction and performance.

Alexium International Announces Investor Webinar to Engage Shareholders

Alexium International Group Limited has announced an investor webinar scheduled for October 16, 2025, in Sydney and October 15, 2025, in Greer. The event will feature presentations from key company leaders, including the Interim Chair, CEO, and Vice President of Finance. This initiative aims to engage shareholders by allowing them to submit questions during the webinar, potentially enhancing transparency and communication with stakeholders.

Alexium Announces Director’s Change in Securities

Alexium International Group Limited has announced a change in the director’s interest, specifically concerning William Timothy Blackburn. The change involves the lapse of 22,843,648 Share Appreciation Rights, resulting in a decrease of securities held by the director. This adjustment reflects the company’s ongoing management of executive compensation and may influence shareholder perceptions regarding executive incentives and alignment with company performance.

Alexium International Announces Cessation of Securities

Alexium International Group Limited announced the cessation of 32,476,019 share appreciation rights due to the expiry of options or other convertible securities without exercise or conversion as of September 23, 2025. This development may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial strategies and market positioning.

Alexium International Postpones Investor Webinar to Mid-October

Alexium International Group Limited has announced the postponement of its Investor Webinar originally scheduled for September 25-26, 2025. The webinar will now take place on October 15-16, 2025, and will provide a comprehensive update on the company’s business and new business opportunities that are in advanced stages of development. This postponement may impact stakeholders’ expectations and the company’s communication strategy.

Alexium Director Increases Shareholding Through Remuneration Plan

Alexium International Group Limited announced a change in the director’s interest, with Paul Stenson acquiring 2,981,037 ordinary fully paid shares. These shares were issued in lieu of director remuneration for the first half of 2025, as approved by shareholders at the 2024 Annual General Meeting. This move reflects the company’s strategy to align management incentives with shareholder interests, potentially impacting its financial structure and stakeholder relations.

Alexium Director Increases Stake Through Share Remuneration

Alexium International Group Limited announced a change in the director’s interest, with T. Randall Lane acquiring 5,962,075 ordinary fully paid shares, increasing his total holdings to 7,899,743 shares. This acquisition was made in lieu of director remuneration for the first half of 2025, as approved by shareholders, indicating a strategic move to align the director’s interests with the company’s performance, potentially impacting stakeholder confidence and market perception positively.

Alexium International Announces Director’s Interest Change

Alexium International Group Limited announced a change in the director’s interest, with Simon Colinton Moore receiving shares in lieu of remuneration for the first half of 2025. This adjustment, approved by shareholders, reflects the company’s strategic approach to aligning director interests with company performance, potentially impacting stakeholder perceptions and reinforcing the company’s commitment to its financial strategies.

Alexium International Issues New Shares Under Regulatory Compliance

Alexium International Group Limited has issued 22,701,738 ordinary fully paid shares without disclosure under Part 6D.2 of the Corporations Act, as per a notice under section 708A(5) of the Act. The company confirms compliance with relevant provisions of the Corporations Act and states there is no ‘excluded information’ required to be disclosed. This move is authorized by the Board of Directors and reflects the company’s ongoing commitment to regulatory compliance and transparency.

Alexium International Issues New Shares for Director Remuneration

Alexium International Group Limited announced the issuance of 22,701,738 ordinary shares as part of director remuneration, approved at the company’s Annual General Meeting in November 2024. This move is expected to impact the company’s financial structure and could influence its market positioning by aligning director interests with shareholder value.